The Blog
-
Mar 05, 2025Resmetirom: A Breakthrough Treatment for MASH and the Future of Liver Disease Management
READ MORE -
Mar 04, 2025Laduviglusib: A GSK3β Inhibitor with Potential Across Multiple Diseases
READ MORE -
Feb 28, 2025The Role of EGF (Epidermal Growth Factor) in the Construction of Organoid Models
READ MORE -
Feb 28, 2025Hexamethyldisiloxane (HMDSO): A Versatile Compound in Electronics, Coatings, and Beyond
READ MORE -
Feb 27, 2025Economic Considerations and Future Outlook for Resmetirom in the Treatment of MASH
READ MORE -
Feb 21, 2025Cariprazine in Major Depressive Disorder: A Promising Adjunctive Treatment for Treatment-Resistant Depression
READ MORE -
Feb 20, 2025Is the Drug Activity Designed by AI Reliable?
READ MORE -
Feb 19, 2025Inventory of antifungal drugs: innovation and challenges coexist
READ MORE -
Feb 17, 2025Zenocutuzumab: A Dual-Targeted Monoclonal Antibody for HER2 and HER3-Driven Cancers
READ MORE